Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma with obstructive jaundice: A case report and review of literature

Table 1 Laboratory examination results on admission

Blood tests	Result	Normal
AFP (ng/mL)	1658	< 7
HBV DNA (IU/mL)	5.374 × 103	< 1.0 × 102
TBIL (μmol/L)	140	< 26
DBIL (μmol/L)	128.7	0-8
ALB (g/L)	26.1	40-55
ALT (U/L)	135	< 50
AST (U/L)	188	< 40
GGT (U/L)	132	10-60

AFP: Alpha-fetoprotein; HBV: Hepatitis B virus; TBIL: Total bilirubin; DBIL: Direct bilirubin; ALB: Albumin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase.

Table 2 Laboratory test results of each cycle during hepatic artery infusion chemotherapy treatment

Blood tests	Normal	Baseline	After HAIC treatment
			Cycle 1	Cycle 2	Cycle 3	Cycle 4	Cycle 5	Cycle 6
TBIL (μmol/L)	0-26	209.3	51.5	39.8	29.3	35	29.2	31.6
DBIL (μmol/L)	0-8	175.1	43.95	29.1	16.02	15.24	13.4	15.55
ALT (U/L)	9-50	108	587	172	76	58	56	47
AST (U/L)	15-40	326	688	220	96	75	75	66
GGT (U/L)	10-60	207	182	117	76	63	54	60
ALB (g/L)	40-55	33.1	28.8	32.3	20.6	18.2	31	31.9
AFP (ng/mL)	0-7	1658	455.4	17.1	20.6	18.2	18.8	27.6

HAIC: Hepatic artery infusion chemotherapy; AFP: Alpha-fetoprotein; TBIL: Total bilirubin; DBIL: Direct bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; ALB: Albumin.